Daugaard I, Sanders K J, Idica A, Vittayarukskul K, Hamdorf M, Krog J D, Chow R, Jury D, Hansen L L, Hager H, Lamy P, Choi C L, Agalliu D, Zisoulis D G, Pedersen I M
Department of Molecular Biology and Biochemistry, Francisco J. Ayala School of Biological Sciences, University of California, Irvine, CA, USA.
Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Oncogenesis. 2017 Jul 31;6(7):e366. doi: 10.1038/oncsis.2017.66.
miR-151a and its host gene, focal adhesion kinase, FAK, are located in a region of chromosome 8q that is frequently amplified in solid tumors, including lung cancer. Lung cancer is the leading cause of cancer deaths worldwide and metastasis remains the major challenge in battling lung cancer mortality. Here, we demonstrate that miR-151a is overexpressed in non-small cell lung cancer (NSCLC) patient specimens, as compared to healthy lung. In addition, miR-151a overexpression promotes proliferation, epithelial-to-mesenchymal transition (EMT) and induces tumor cell migration and invasion of NSCLC cells. Blocking miR-151a expression using anti-miR-151a approaches significantly reduced NCSLC cell proliferative and motility potential. Furthermore, we determined that miR-151a significantly regulates E-cadherin expression. Finally, functional rescue experiments determined that overexpression of E-cadherin in miR-151a NSCLC cell lines potently repressed miR-151a-induced partial EMT and cell migration of NSCLC cells. In conclusion, our findings suggest that miR-151a functions as an oncomiR in NSCLC by targeting E-cadherin mRNA and inducing proliferation, migration and partial EMT.
miR-151a及其宿主基因粘着斑激酶(FAK)位于8号染色体q区域,该区域在包括肺癌在内的实体瘤中经常发生扩增。肺癌是全球癌症死亡的主要原因,转移仍然是对抗肺癌死亡率的主要挑战。在这里,我们证明与健康肺组织相比,miR-151a在非小细胞肺癌(NSCLC)患者标本中过表达。此外,miR-151a的过表达促进增殖、上皮-间质转化(EMT),并诱导NSCLC细胞的肿瘤细胞迁移和侵袭。使用抗miR-151a方法阻断miR-151a表达可显著降低NCSLC细胞的增殖和运动潜能。此外,我们确定miR-151a显著调节E-钙粘蛋白的表达。最后,功能挽救实验确定在miR-151a NSCLC细胞系中过表达E-钙粘蛋白可有效抑制miR-151a诱导的NSCLC细胞部分EMT和细胞迁移。总之,我们的研究结果表明,miR-151a在NSCLC中作为一种癌基因,通过靶向E-钙粘蛋白mRNA并诱导增殖、迁移和部分EMT发挥作用。